131 related articles for article (PubMed ID: 38854781)
1. Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation.
Kamel NA; Abdalla MS; Al Ali A; Alshahrani MY; Aboshanab KM; El Borhamy MI
Infect Drug Resist; 2024; 17():2249-2260. PubMed ID: 38854781
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem-cell transplantation in a zoo of multidrug-resistant organisms: Data from a cancer center in eastern India.
Ghosh S; Bhattacharya S; Goel G; Deshmukh RA; Javed R; Roychowdhury M; Sinha S; De MS; Nag A; Kumar J; Bhave SJ; Nair R; Chandy M
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14072. PubMed ID: 37260056
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of surveillance cultures for high priority multidrug-resistant bacteria in hematopoietic stem cell transplant units.
Mendes ET; Salomão MC; Tomichi LM; Oliveira MS; Graça M; Rossi F; Sapadao F; Guimarães T; Rocha V; Costa SF
Rev Inst Med Trop Sao Paulo; 2021; 63():e77. PubMed ID: 34755816
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients.
Chen W; Zhao Y; Luo Y; Yu J; Fu H; Lai X; Liu L; Ye Y; He J; Sun J; Zheng W; Zhao Y; Wei G; Cai Z; Huang H; Shi J
Infect Drug Resist; 2022; 15():6893-6905. PubMed ID: 36465805
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.
Verma A; Vimalesvaran S; Dhawan A
Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326850
[TBL] [Abstract][Full Text] [Related]
6. Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
Patel C; Pasciolla M; Abramova R; Salerno D; Gomez-Arteaga A; Shore TB; Orfali N; Mayer S; Hsu J; Phillips AA; Chaekal OK; Satlin MJ; Soave R; Kodiyanplakkal RPL; Drelick A; Plate M; Besien KV
Transplant Cell Ther; 2023 Feb; 29(2):132.e1-132.e5. PubMed ID: 36334653
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients.
Mellouli A; Chebbi Y; El Fatmi R; Raddaoui A; Lakhal A; Torjmane L; Ben Abdeljelil N; Belloumi D; Ladeb S; Ben Othmen T; Achour W
Tunis Med; 2021 Feb; 99(2):269-276. PubMed ID: 33899198
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
Scheich S; Lindner S; Koenig R; Reinheimer C; Wichelhaus TA; Hogardt M; Besier S; Kempf VAJ; Kessel J; Martin H; Wilke AC; Serve H; Bug G; Steffen B
Cancer; 2018 Jan; 124(2):286-296. PubMed ID: 28960264
[TBL] [Abstract][Full Text] [Related]
10. Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Gonçalves LA; Anjos BB; Tavares BM; Marchi AP; Côrtes MF; Higashino HR; de Carvalho Moraes BDG; Bampi JVB; Pinheiro LD; Spadao FS; Rocha V; Guimarães T; Costa SF
Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786176
[TBL] [Abstract][Full Text] [Related]
11. Alarming prevalence of community-acquired multidrug-resistant organisms colonization in children with cancer and implications for therapy: A prospective study.
Thacker N; Pereira N; Banavali SD; Narula G; Vora T; Chinnaswamy G; Prasad M; Kelkar R; Biswas S; Arora B
Indian J Cancer; 2014; 51(4):442-6. PubMed ID: 26842153
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
[TBL] [Abstract][Full Text] [Related]
13. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
[TBL] [Abstract][Full Text] [Related]
14. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
[TBL] [Abstract][Full Text] [Related]
15. Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.
Jolivet S; Lolom I; Bailly S; Bouadma L; Lortat-Jacob B; Montravers P; Armand-Lefevre L; Timsit JF; Lucet JC
J Hosp Infect; 2020 May; 105(1):10-16. PubMed ID: 32092367
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
Satlin MJ; Walsh TJ
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
[TBL] [Abstract][Full Text] [Related]
17. [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?].
Yeşilbağ Z; Çağatay AA; Karadeniz A; Başaran S; Orhun G; Ergin Özcan P; Özsüt H; Eraksoy H
Mikrobiyol Bul; 2015 Jul; 49(3):327-39. PubMed ID: 26313275
[TBL] [Abstract][Full Text] [Related]
18. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Risk Factors and Outcome of Bloodstream Infections in Patients After Hematopoietic Stem-Cell Transplantation: A Single Center Study.
Niyazi D; Micheva I; Dokova K; Stoeva T
Indian J Hematol Blood Transfus; 2023 Apr; 39(4):1-5. PubMed ID: 37362402
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants.
Korula A; Perumalla S; Devasia AJ; Abubacker FN; Lakshmi KM; Abraham A; Mathews V; Srivastava A; Anandan S; Veeraraghavan B; George B
Transpl Infect Dis; 2020 Jun; 22(3):e13273. PubMed ID: 32107829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
